Van de Werf F
Kliniek voor Cardiologie, U.Z. Gasthuisberg, Katholieke Universiteit Leuven.
Verh K Acad Geneeskd Belg. 1994;56(3):211-27; discussion 227-30.
The favourable effects of thrombolytic therapy on survival after acute myocardial infarction can not be attributed solely to a partial recovery of systolic left ventricular function. This is mainly due to the fact that with the current therapeutic regimens early, optimal tissue reperfusion is obtained in only a small percentage of patients with an acute myocardial infarction. However, recanalization of an occluded coronary vessel in itself has beneficial effects by mechanisms other than salvage of ischemic myocardium and preservation of left ventricular function. In view of the striking relationship between reperfusion (early or late) and survival as recently demonstrated by the GUSTO study, new therapeutic developments must be aimed at increasing the percentage of early, optimal and persistent reperfusion.
溶栓治疗对急性心肌梗死后生存率的有益影响不能仅仅归因于左心室收缩功能的部分恢复。这主要是因为按照目前的治疗方案,只有一小部分急性心肌梗死患者能实现早期、最佳的组织再灌注。然而,闭塞冠状动脉的再通本身通过除挽救缺血心肌和保留左心室功能之外的机制产生有益作用。鉴于最近GUSTO研究表明的再灌注(早期或晚期)与生存率之间的显著关系,新的治疗进展必须旨在提高早期、最佳和持续性再灌注的比例。